-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
The NL003 project has passed the drug registration inspection.
The NORTHLAND NL003 project recently passed the drug registration inspection conducted by the China National Institute for Drug and Biological Products Control. The inspection report indicates that all test results for this drug comply with the relevant regulations.
According to the progress inquiry from the SFDA Review Center, this product has completed part of the technical review and will proceed to the next stage of review once we receive the drug testing report. The company will meticulously and thoroughly prepare all relevant application documents, striving to obtain the clinical research approval for this product at the earliest possible date.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005